Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A drug to boost memory?

Published on: 12/10/2016 Reading time: 1 min
cerveau

Methamphetamine is a highly addictive psychostimulant drug. Its effects depend on the dose and time of administration. Importantly, it is used in the United States to treat attention deficit hyperactivity disorder (ADHD). Ph.D. student Sofia Baptista from Alberto Bacci’s team and their colleagues looked at the effects of methamphetamine on a model which mimics the treatment as it is prescribed in the US. Their results show the effects of treatment on certain neurons that could have a positive effect on memory. These results were published in eNeuro on June, 2016.

The use of methamphetamine (METH), a drug of abuse, has increased all around the world. METH is a psychostimulant affecting the functions of hippocampus, a brain area involved in memory, learning, navigation and decision making. Abuse or misuse of methamphetamine can lead to memory deficits and a decrease of hippocampal volume. However, METH’s cognitive effects vary depending on the dose and time of administration, ranging from memory enhancement to impairment. Importantly, in the United States, METH is approved for the treatment of attention deficit hyperactivity disorder (ADHD). People with ADHD have trouble focusing or being attentive and tend to act impulsively.

In this study, researchers focused on the impact of a medium-term (1 week) treatment with low doses of methamphetamine on the generation of new neurons and their plasticity. The doses that were used mimicked ADHD treatment.

Generation of new neurons (or neurogenesis) in a specific area called dentate gyrus (part of the hippocampal formation) contributes to the formation and consolidation of new memories. Previous studies showed that neurogenesis can be affected by METH, depending on the dose and frequency of administration. Intermittent access to METH, which mimics a human recreational use, increases proliferation of specific dentate gyrus cells, whereas a short-term or long-term daily use of this drug lead to a decrease in number of these cells. In vitro studies also showed the negative impact of METH on dentate gyrus stem cells (essential for production of new neurons).

The results of Alberto Bacci’s team show an acceleration of the maturation of immature neurons (immediately following neurogenesis), accompanied by increased synaptic potentiation of dentate gyrus granule cells at more mature differentiating stages. Synaptic potentiation is a form of synaptic plasticity believed to underlie learning and memory.
They propose that administration of medium-term treatment with low doses of methamphetamine reinforces synaptic plasticity at a specific stage of granule cells’ maturation and could therefore affect positively memory performances.

In light of these results, it is now very important to understand how prolonged use of METH will convert such “positive” effects on neurogenesis and synaptic plasticity into the deleterious effects on cognitive performance in METH-addicted subjects.

 

Sources

Long-Term Treatment with Low Doses of Methamphetamine Promotes Neuronal Differentiation and Strengthens Long-Term Potentiation of Glutamatergic Synapses onto Dentate Granule Neurons. Sofia Baptista, Joana Lourenço, Nuno Milhazes, Fernanda Borges, Ana Paula Silva, et Alberto Bacci. eNeuro, 11 July 2016.
https://www.ncbi.nlm.nih.gov/pubmed/27419216

Our news on the subject

Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of...
05.30.2024 Research, science & health
Population de bactéries commensales (en rouge) dans un intestin grêle de souris. Crédit : University of Chicago
The composition of the gut microbiota could influence decision-making
The way we make decisions in a social context can be explained by psychological, social, and political factors. But what if other forces were at work? Hilke Plassmann and her colleagues from the Paris Brain Institute and the University of Bonn show...
05.16.2024 Research, science & health
See all our news